Among them, the rates of programmed death-receptor ligand-1 (PD-L1) tumor proportion score (TPS) ≥1% and ≥50% were 50% and 16%, respectively, and no significant relation between PD-L1 expression and ALK fusion variants was found. Here, ALK is linked to neoplasm.